An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, regulating gamma hydroxybutyric acid; prohibiting certain advertisements by electronic transmission; and further providing for prohibited acts.